R. Falzarano

Randomized controlled trials versus real-life studies: bridging the gap

M. S. Magnoni, V. Bocchino, Gioacchino Riccardo, 2021 .

Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers

L. Frati, S. Michienzi, F. Longo, 2013, Tumor Biology.

Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer.

L. Frati, S. Michienzi, L. Manganaro, 2013, Oncology reports.

CLEIA CA125 evidences: good analytical performance avoiding “Hook effect”

L. Frati, S. Michienzi, F. Longo, 2013, Tumor Biology.

The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer

L. Frati, M. Porpora, P. Panici, 2013, Journal of Ovarian Research.